Beyond COVID: Leveraging synthetic biology to advance the potential of mRNA-based vaccines
Join us for our recorded webinar presented at SynBioBeta 2023 to explore the groundbreaking potential of synthetic biology in advancing mRNA-based vaccines.
- Discover how Telesis Bio addresses the bottlenecks in vaccine discovery.
- Learn about the collaboration with RNAimmune and the BioXp platform for faster vaccine screening.
- Gain insights into the future of mRNA-based vaccines, including the potential of RNA encapsulation on the BioXp platform.
President, Chief Operating Officer
David Brown, PhD.
"*" indicates required fields